Literature DB >> 22197577

Chronic bronchitis in the general population: influence of age, gender and socio-economic conditions.

Alexis Ferré1, Claire Fuhrman, Mahmoud Zureik, Christos Chouaid, Alain Vergnenègre, Gérard Huchon, Marie-Christine Delmas, Nicolas Roche.   

Abstract

Chronic bronchitis (CB) is an indicator of an increased risk of developing COPD, but its symptoms are often underestimated. Demographic and socio-economic conditions might influence its prevalence, reporting and impact. Data from a large epidemiological survey of the French general population were analyzed to determine the burden of CB, the magnitude of under-diagnosis and the influence of age, gender and socio-economic conditions. Altogether, 9050 participants aged 45 years or more provided complete data. The prevalence of symptoms and diagnosis of CB was 3.5% and 3.4%, respectively. CB was associated with impaired health status and activity and, in women, work loss. Among subjects with symptoms of CB, only 28.6% declared a known diagnosis of respiratory disease. Factors associated with symptoms of CB in multivariate analysis were male gender, active smoking, lower income and occupational category: the highest prevalence was observed in manual workers (5.6%) and self-employed subjects (5.2%). The under-diagnosis of CB was more marked in men and subjects of higher socio-economic categories. These results confirm that CB is markedly under-diagnosed in the general population. Socio-economic conditions influence both its prevalence (higher in low categories) and rate of diagnosis (lower in high categories), which should be considered when elaborating prevention and detection campaigns.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22197577     DOI: 10.1016/j.rmed.2011.12.002

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  19 in total

Review 1.  The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications.

Authors:  Victor Kim; Gerard J Criner
Journal:  Curr Opin Pulm Med       Date:  2015-03       Impact factor: 3.155

2.  The clinical impact of non-obstructive chronic bronchitis in current and former smokers.

Authors:  Carlos H Martinez; Victor Kim; Yahong Chen; Ella A Kazerooni; Susan Murray; Gerard J Criner; Jeffrey L Curtis; Elizabeth A Regan; Emily Wan; Craig P Hersh; Edwin K Silverman; James D Crapo; Fernando J Martinez; Meilan K Han
Journal:  Respir Med       Date:  2013-11-15       Impact factor: 3.415

3.  Prevalence of and risk factors for chronic bronchitis in a Canadian population: the Canadian Community Health Survey, 2007 to 2008.

Authors:  Chandima P Karunanayake; Briana Hagen; James A Dosman; Punam Pahwa
Journal:  Can Respir J       Date:  2013-05-28       Impact factor: 2.409

4.  Grading Severity of Productive Cough Based on Symptoms and Airflow Obstruction.

Authors:  Rodrigo Vazquez Guillamet; Hans Petersen; Paula Meek; Akshay Sood; Yohannes Tesfaigzi
Journal:  COPD       Date:  2018-04-26       Impact factor: 2.409

5.  Efficacy and safety of B-mode ultrasound-guided percutaneous transhepatic gallbladder drainage combined with laparoscopic cholecystectomy for acute cholecystitis in elderly and high-risk patients.

Authors:  Yi-Ren Hu; Jiang-Hua Pan; Xiao-Chun Tong; Ke-Qin Li; Sen-Rui Chen; Yi Huang
Journal:  BMC Gastroenterol       Date:  2015-07-09       Impact factor: 3.067

6.  Chronic respiratory disease among the elderly in South Africa: any association with proximity to mine dumps?

Authors:  Vusumuzi Nkosi; Janine Wichmann; Kuku Voyi
Journal:  Environ Health       Date:  2015-04-03       Impact factor: 5.984

7.  Susceptibility to chronic mucus hypersecretion, a genome wide association study.

Authors:  Akkelies E Dijkstra; Joanna Smolonska; Maarten van den Berge; Ciska Wijmenga; Pieter Zanen; Marjan A Luinge; Mathieu Platteel; Jan-Willem Lammers; Magnus Dahlback; Kerrie Tosh; Pieter S Hiemstra; Peter J Sterk; Avi Spira; Jorgen Vestbo; Borge G Nordestgaard; Marianne Benn; Sune F Nielsen; Morten Dahl; W Monique Verschuren; H Susan J Picavet; Henriette A Smit; Michael Owsijewitsch; Hans U Kauczor; Harry J de Koning; Eva Nizankowska-Mogilnicka; Filip Mejza; Pawel Nastalek; Cleo C van Diemen; Michael H Cho; Edwin K Silverman; James D Crapo; Terri H Beaty; David A Lomas; Per Bakke; Amund Gulsvik; Yohan Bossé; Ma'en Obeidat; M A Obeidat; Daan W Loth; Lies Lahousse; Fernando Rivadeneira; Andre G Uitterlinden; Andre Hofman; Bruno H Stricker; Guy G Brusselle; Cornelia M van Duijn; Uilke Brouwer; Gerard H Koppelman; Judith M Vonk; Martijn C Nawijn; Harry J M Groen; Wim Timens; H Marike Boezen; Dirkje S Postma
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

8.  Influence of socioeconomic and demographic status on spirometry testing in patients initiating medication targeting obstructive lung disease: a population-based cohort study.

Authors:  Mette M Koefoed; Jens Søndergaard; René dePont Christensen; Dorte E Jarbøl
Journal:  BMC Public Health       Date:  2013-06-14       Impact factor: 3.295

9.  Chronic bronchitis is an independently associated factor for more symptom and high-risk groups.

Authors:  Joon Young Choi; Hyoung Kyu Yoon; Seoung Ju Park; Yong Bum Park; Kyeong-Cheol Shin; Ju Ock Na; Kwang Ha Yoo; Ki-Suck Jung; Young Kyoon Kim; Chin Kook Rhee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-06-21

10.  Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease.

Authors:  Jin Hwa Lee; Michael H Cho; Craig P Hersh; Merry-Lynn N McDonald; James D Crapo; Per S Bakke; Amund Gulsvik; Alejandro P Comellas; Christine H Wendt; David A Lomas; Victor Kim; Edwin K Silverman
Journal:  Respir Res       Date:  2014-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.